An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments.
Cognitive debriefing
Concept elicitation
Delphi panel
Exit interviews
Focus groups
Important change
Meaningful change thresholds
Responder definition
Vignettes
Journal
Journal of patient-reported outcomes
ISSN: 2509-8020
Titre abrégé: J Patient Rep Outcomes
Pays: Germany
ID NLM: 101722688
Informations de publication
Date de publication:
04 Mar 2019
04 Mar 2019
Historique:
received:
06
06
2018
accepted:
21
01
2019
entrez:
5
3
2019
pubmed:
5
3
2019
medline:
5
3
2019
Statut:
epublish
Résumé
Establishing meaningful change thresholds for Clinical Outcome Assessments (COA) is critical for score interpretation. While anchor- and distribution-based statistical methods are well-established, qualitative approaches are less frequently used. This commentary summarizes and expands on a symposium presented at the International Society for Quality of Life Research (ISOQOL) 2017 annual conference, which provided an overview of qualitative methods that can be used to support understanding of meaningful change thresholds on COAs. Further published literature and additional examples from multiple disease areas which have also qualitatively explored the concept of meaningful change are presented.Semi-structured interviews conducted independently from a clinical trial, exit interviews conducted in the context of a clinical trial, focus groups, vignettes and the Delphi panel method can be used to obtain data regarding meaningful change thresholds, with advantages and disadvantages to each method. Semi-structured interviews using concept elicitation (CE) or cognitive debriefing (CD) methods conducted independently from a clinical trial can be an efficient way to gain in-depth patient/caregiver insights. However, there can be challenges with reconciling heterogeneous data across diverse samples and in interpreting the qualitative insights in the context of quantitative score changes. Semi-structured qualitative interviews using CE/CD methods embedded as exit interviews in a clinical trial context with patients/caregivers can provide insights which can augment quantitative findings based on analysis of clinical trial data. However, there are logistical challenges relating to embedding the interviews in a clinical trial.Focus groups and the Delphi panel method can be valuable for reaching consensus regarding meaningful change thresholds; however, for face-to-face interactions, social desirability bias can affect responses. Finally, using vignettes and taking a mixed methods approach can aid in achieving consensus on the minimum score change endorsed by respondents as a meaningful improvement/decrement. However, the approach can be cognitively challenging for participants and reaching a consensus is not guaranteed.Anchor- and distribution- based methods remain critical in establishing responder definitions. Nonetheless, qualitative data has the potential to provide complementary support that a certain level of change on the target COA, which has been statistically supported, is truly important and meaningful for the target population.
Identifiants
pubmed: 30830492
doi: 10.1186/s41687-019-0100-y
pii: 10.1186/s41687-019-0100-y
pmc: PMC6399361
doi:
Types de publication
Letter
Langues
eng
Pagination
16Références
Value Health. 2019 Mar;22(3):340-347
pubmed: 30832972
J Clin Epidemiol. 2008 Feb;61(2):102-9
pubmed: 18177782
J Orthop Surg Res. 2015 Feb 03;10:24
pubmed: 25645576
Value Health. 2015 Jan;18(1):110-5
pubmed: 25595241
Clin Ther. 2016 Apr;38(4):759-68
pubmed: 27041406
J Chronic Dis. 1987;40(2):171-8
pubmed: 3818871
Adv Ther. 2017 Dec;34(12):2680-2692
pubmed: 29079987
Control Clin Trials. 1989 Dec;10(4):407-15
pubmed: 2691207
Mayo Clin Proc. 2002 Apr;77(4):384-92
pubmed: 11936936
Value Health. 2011 Dec;14(8):967-77
pubmed: 22152165
Expert Rev Pharmacoecon Outcomes Res. 2011 Apr;11(2):163-9
pubmed: 21476818
Expert Rev Pharmacoecon Outcomes Res. 2011 Apr;11(2):171-84
pubmed: 21476819
J Rheumatol. 1991 Dec;18(12):1908-15
pubmed: 1795330
Mayo Clin Proc. 2002 Apr;77(4):371-83
pubmed: 11936935
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Qual Life Res. 2002 May;11(3):207-21
pubmed: 12074259
J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9
pubmed: 9845158
J Rheumatol. 1992 Mar;19(3):451-7
pubmed: 1578462
Value Health. 2017 Jul - Aug;20(7):838-855
pubmed: 28712612
J Patient Rep Outcomes. 2017;1(1):9
pubmed: 29757313
PLoS One. 2011;6(6):e20476
pubmed: 21694759
Qual Life Res. 2015 Mar;24(3):575-89
pubmed: 25148759
Ther Innov Regul Sci. 2016 Jan;50(1):22-29
pubmed: 30236016
J Gen Intern Med. 2003 Mar;18(3):196-202
pubmed: 12648251
BMC Neurol. 2017 Apr 4;17(1):68
pubmed: 28376816
Innov Clin Neurosci. 2013 May;10(5-6 Suppl A):4S-19S
pubmed: 23882433
J Sex Med. 2013 Oct;10(10):2484-96
pubmed: 23347610